<p>Distribution of neurocognitive impairment, expressed as MDZ scores ±SD, in the patients enrolled at baseline (T0) and after 10 years.</p
<p>Abnormal cut-off scores and frequency of patients with cognitive impairments.</p
<p>Kaplan-Meier curves of the risk of developing cognitive dysfunction according to disability statu...
<p>Changes of proportion of RRMS patients with Cognitive Impairment (CI) after 1–2 year Natalizumab ...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores±SD, in the patients enrolled (...
<p>Global prevalence of neurocognitive impairment in each treatment group and by presence of comorbi...
10-year change in distributions of cognitive status based on TICS score, HRS and FEM.</p
<p>Distribution of clinical factors by presence of brain metastases at baseline or development of su...
<p>The percent of patients with impairment in GCS at a cutoff of 85 (1SD below the normalized mean, ...
<p>Change in scores on Neuropsychiatric Inventory-10 Questionnaire (NPI-Q -10), the Physical Self Ma...
<p>Panel a) 90% of the population are ‘normal’ and have a mean (standard deviation) T-score of 50 (1...
<p>Number of patients showing any impairment on neuropsychological assessments.</p
Dementia is a group of diseases that are caused by neurocognitive disorder. It is the second leading...
<p>AIDS patients with CD4 counts <300 cells/µl were classified based on plasma LPS levels at one (n ...
<p>Abbreviations: RR-MS = relapsing-remitting MS; PP-MS = primary-progressive MS; CLVT = California ...
<p>Number of participants in each stratum of the Neuropathological Comorbidity Score (NPCS) accordin...
<p>Abnormal cut-off scores and frequency of patients with cognitive impairments.</p
<p>Kaplan-Meier curves of the risk of developing cognitive dysfunction according to disability statu...
<p>Changes of proportion of RRMS patients with Cognitive Impairment (CI) after 1–2 year Natalizumab ...
<p>Distribution of neurocognitive impairment, expressed as MDZ scores±SD, in the patients enrolled (...
<p>Global prevalence of neurocognitive impairment in each treatment group and by presence of comorbi...
10-year change in distributions of cognitive status based on TICS score, HRS and FEM.</p
<p>Distribution of clinical factors by presence of brain metastases at baseline or development of su...
<p>The percent of patients with impairment in GCS at a cutoff of 85 (1SD below the normalized mean, ...
<p>Change in scores on Neuropsychiatric Inventory-10 Questionnaire (NPI-Q -10), the Physical Self Ma...
<p>Panel a) 90% of the population are ‘normal’ and have a mean (standard deviation) T-score of 50 (1...
<p>Number of patients showing any impairment on neuropsychological assessments.</p
Dementia is a group of diseases that are caused by neurocognitive disorder. It is the second leading...
<p>AIDS patients with CD4 counts <300 cells/µl were classified based on plasma LPS levels at one (n ...
<p>Abbreviations: RR-MS = relapsing-remitting MS; PP-MS = primary-progressive MS; CLVT = California ...
<p>Number of participants in each stratum of the Neuropathological Comorbidity Score (NPCS) accordin...
<p>Abnormal cut-off scores and frequency of patients with cognitive impairments.</p
<p>Kaplan-Meier curves of the risk of developing cognitive dysfunction according to disability statu...
<p>Changes of proportion of RRMS patients with Cognitive Impairment (CI) after 1–2 year Natalizumab ...